Company ProfilePremium

Integrated Research Limited

Company Profile Analysis

Ticker: IRI.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
Integrated Research Limited - Company showcase

Year Founded & Workforce

1988

138 Employees

Integrated Research Limited logo

Integrated Research Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Integrated Research Limited Overview

Integrated Research is a 38-year-old Australian enterprise-software company whose single platform, Prognosis, provides real-time observability for three niche but mission-critical domains:

  • unified communications and contact-centre ecosystems ("Collaborate");

  • card, high-value and real-time payments environments ("Transact");

  • HPE NonStop fault-tolerant infrastructure ("Infrastructure").

Its customers are among the world's largest banks, card processors, telecommunications carriers and Fortune 500 enterprises. JPMorgan Chase, for example, has been a client for about 30 years. Revenue is dominated by multi-year term licences recognised upfront, so statutory results swing with the size of each year's renewal book.

After a decade of structural decline in its on-premise UC franchise, IR has pivoted under CEO Ian Lowe (since October 2024) to a "product-led growth" strategy. That strategy centres on AI-native products (the Iris assistant and IR Labs' Agentic SQA), observability-as-a-service (Prognosis Elevate) and utilisation-based pricing.

The company is debt-free and holds cash roughly equal to its market capitalisation. It is, however, shrinking: FY26 statutory revenue fell 16% to A$57.6m.


Company's own description (FY26 Annual Financial Report, paraphrased)

The FY26 Directors' Report describes IR's principal activities as designing, developing, implementing and selling software that monitors, in real time, the performance of business-critical computing, including UC networks and payment networks.

Prognosis is described as an integrated monitoring and management suite. It gives management and technical staff operational insight into, and helps them optimise:

  • HP NonStop systems;

  • distributed servers;

  • UC and payment environments;

  • the business applications running on those platforms.

The product is built on a fault-tolerant, highly distributed architecture designed for functionality and scalability.

IR reports serving clients in more than 40 countries. It sells through direct sales operations in the USA, UK, Germany, Singapore and Australia, plus a global channel network. Its customer base includes banks, credit-card companies, telecommunications carriers, technology companies, service providers and manufacturers.

The company's current tagline (FY26 market announcements) describes IR as a leading global provider of observability for business-critical IT ecosystems, powered by Prognosis across multi-vendor infrastructure, UC&CX and payments.

Business model and revenue model

Revenue streamRecognitionFY2026 (AUD Mn)% of FY26 revenue (computed)
Licence fees (term licences, 1–5 years)Point in time, on delivery of licence key38.867.3
Maintenance feesRatably over the support term (1–5 years)11.620.2
Subscription (SaaS / hosted) feesRatably over the term1.83.2
Testing solution servicesOver the service period2.13.6
Professional servicesAs rendered / milestones3.35.7
Total—57.6100.0

IR generates revenue from five statutory streams (FY26 Annual Financial Report, Note 3):

The model has five characteristic features.

  1. Product vs. service vs. subscription vs. licensing mix.

    • IR is economically a recurring-revenue business: 92% of FY26 pro forma revenue was secured through term-based contracts (FY26 Investor Presentation).

    • However, it is accounted for as predominantly a licence business. About two-thirds of statutory revenue is term-licence fees recognised upfront.

    • Pure SaaS/subscription revenue is small (A$1.8m in FY26, down 54% year on year).

  2. Pro forma revenue.

    • Management's preferred measure restates term licences on a straight-line, over-time basis.

    • FY26 pro forma revenue was A$65.8m, against statutory revenue of A$57.6m.

  3. Total Contract Value (TCV).

    • TCV is bookings net of residual value from prior related contracts. It was A$54.3m in FY26, made up of:

      • renewals: A$38.5m

      • new business: A$10.9m

      • services: A$4.9m

  4. Extended payment terms.

    • IR commonly grants customers multi-year payment terms (1–5 years).

    • It discounts the transaction price, recognising a financing component as finance income.

    • This is why receivables (A$58.2m at 30 Jun 2026, including A$22.3m non-current) are very large relative to revenue.

  5. New utilisation-based (usage) models.

    • Introduced in FY26 for the new AI products, under which clients pay by consumption rather than upfront commitment (FY26 Investor Presentation).

Value-chain position

IR is an independent software vendor (ISV) in the IT operations / observability layer. It sits above the underlying platforms:

  • HPE NonStop servers;

  • payment switches such as ACI's payment software;

  • UC/contact-centre platforms from vendors such as Microsoft, Cisco and Avaya.

It monitors and correlates their telemetry. IR does not own the platforms it monitors, so its value depends on platform-vendor ecosystems and on the gap between native vendor tooling and enterprise multi-vendor needs.

Customer types and end-markets

Per the FY26 Investor Presentation, IR's clients are concentrated in:

  • technology and telecommunications (leading telcos);

  • banking, financial services and insurance (leading US banks);

  • health, government and education;

  • retail and industrial (Fortune 500 companies and large enterprises).

New-client wins in FY26 included large US Government agencies and clients in health and finance.

Independent characterisation

IR is best understood as a mature, cash-generative niche-monitoring franchise with three distinct sub-businesses:

Infrastructure (HPE NonStop): a highly cash-generative but mature, ex-growth installed base. Management said exactly this in the FY24 Annual Report.

Transact (payments): a small but strategically valuable franchise among top-tier banks and processors. It was the only product line to grow statutory revenue in FY26 (+18%), driven by early renewals.

Collaborate (UC&CX): the historical growth engine, now in structural decline as enterprises migrate from on-premise UC to SaaS platforms with native monitoring. Collaborate's constant-currency net revenue retention was 83% in both FY25 and FY26.

The product-led growth (PLG) pivot is effectively an attempt to build a second-generation, AI-enabled and usage-priced product set on top of the trusted data position Prognosis holds inside client environments, before the legacy base erodes further.

Strategy

Stated corporate strategy (themes from FY25–FY26 filings, paraphrased)

The product-led growth (PLG) strategy was announced in August 2024 and reaffirmed in the FY26 Annual Financial Report. Its five elements are:

  1. Invest in new products to restore sustainable revenue growth over the medium to long term. Management acknowledges IR has a mature product in a competitive global market.

  2. Embed AI three ways:

    • as an innovation driver inside existing products (Iris);

    • as stand-alone, AI-native products (IR Labs / Agentic SQA);

    • as an internal productivity tool.

  3. Lower adoption friction:

    • deployment friction (easier-to-adopt products);

    • pricing friction (usage-based SaaS with no upfront commitment);

    • contract friction (folding new products into existing client contracts).

  4. Retain and expand the core:

    • retention features for NonStop clients;

    • expansion of Transact beyond cards into high-value and real-time payments;

    • Collaborate support for clients' cloud migration (FY24 Annual Report).

  5. FY27 focus: improve the velocity of innovation and commercialisation, expand client engagement, minimise churn, and grow new-client, expansion and SaaS revenue (FY26 Investor Presentation).

The remuneration framework restates the strategy as maximising cash from the existing Collaborate, Transact and Infrastructure lines and reinvesting capital in new product lines (FY26 Remuneration Report).

Strategic initiatives in the last 24 months (Oct 2024 – Oct 2026)

InitiativeDateDescriptionStatus
IR Labs innovation incubatorLaunched Aug 2024Small cross-functional squads building stand-alone AI productsActive; flagship Agentic SQA in beta/MVP
Testing solutions divestmentDec 2024Non-core testing products sold to Voxology to focus resourcesCompleted; A$1.2m gain in FY25
HVP productFirst client Apr 2025Expands Transact into Fedwire/SWIFT/CHIPS flowsImplementation complete with a top-10 US bank; other global banks engaged
IR Hosted Prognosis → Prognosis ElevateFirst sale FY25; launched 4 Nov 2025Observability-as-a-service for UC&CLive
Iris AI interface2 Dec 2025Natural-language AI layer in PrognosisFirst clients activated
Iris for Card PaymentsBeta from May 2026 (Prognosis 13.3)Domain-specific AI assistant for card paymentsBeta, free with usage limits; extensions to HVP and real-time payments planned
Agentic SQABeta/MVP in FY26Stand-alone agentic AI software-quality productFirst clients activated
Utilisation-based pricingFY26Usage-based SaaS model for AI productsIntroduced
Product and technology investment upliftFY26Spend +29% to A$17.4m (30% of revenue), with no capitalisationContinuing into FY27
Cost reallocationFY26Sales and marketing −10%; G&A ex-credit losses reducedAchieved
Capital allocation frameworkPublished 27 Aug 2026See 10.4Active

Sustainability and ESG commitments

These are limited:

  • an ESG Steering Committee (formed FY23);

  • sustainable office selection and recycling;

  • preparation for mandatory climate reporting (Group 3, for financial years starting on or after 1 Jul 2027).

Capital allocation framework, FY27 (FY26 Investor Presentation)

BucketMedium-term allocation of available capitalPurpose
Innovation investment30–35%Product innovation across Prognosis and IR Labs
Flexibility reserves20–35%Opportunistic deals, e.g., right-sized, synergistic M&A in growth markets
Contingency reserves30–35%Working capital and operating cash needs
Shareholder returnsDividend policy: at least 25% of free cash flow (Board discretion)FY26: 3.0c ordinary plus 2.0c special

Management guidance and medium-term targets

No numerical FY27 revenue or EBITDA guidance has been issued: - Management states that investment in PLG will weigh on profit over the short to medium term, and that the FY27 renewals book is weighted to the second half.

Implicit target: the FY26 LTI requires underlying basic EPS CAGR of at least 10% from 6.84c (FY25 base) to FY28. Full vesting therefore implies FY28 UBEPS of about 9.1c, against FY26 basic EPS of 0.67c.

Historical framework (FY24 AGM): allocate up to an additional 10% of TCV a year to product innovation for new revenue. This was superseded by the FY27 capital allocation framework.

Products & Services

All products are delivered on, or alongside, the Prognosis platform.

Current version: 13.x. Version 13.3 was released in about May 2026, per the IR Transact 13.3 release notes and the June 2026 PR.

Pricing: list prices are not publicly disclosed. Contracts are typically term licences of one to five years (average 3.2 years in FY26) with attached maintenance. New AI products use utilisation (usage-based) pricing.

Prognosis platform (core)

AttributeDetail
DescriptionReal-time monitoring, analytics and management platform for multi-vendor, business-critical environments
ArchitectureFault-tolerant, highly distributed; deployable on-premise, hybrid, or IR-hosted (Elevate)
Scale claimMonitors more than 80 billion payment transactions a year for large banks and financial institutions (IR / PR Newswire, Jun 2026)
Target customerLarge enterprises in banking/payments, telecoms, government, health and Fortune 500 companies
Latest versionPrognosis 13.3 (2026)

IR Collaborate (UC&C and contact-centre observability)

OfferingDescriptionTarget customerLaunch / latestPricing model
Collaborate (Prognosis for UC&C)Performance management, analytics and troubleshooting across voice, video, web and collaboration ecosystems; on-premise, cloud or hybrid; multi-vendorLarge enterprises with complex UC/contact-centre estatesLong-standing; continuously releasedTerm licence plus maintenance; some SaaS
Collaborate cloud/SaaSCloud-delivered Collaborate monitoring; Collaborate SaaS revenue was A$1.8m in FY26 (+6%)Enterprises migrating to UCaaS/CCaaSFY21–22 onwards (Prognosis Cloud)Subscription
Collaborate Space ManagementAnalytics on meeting-room/space utilisationEnterprise facilities and IT teamsLaunched FY22—
Prognosis ElevateFully managed observability-as-a-service for UC&C. IR hosts and operates Prognosis for the client. First new business secured in FY25 as "IR Hosted Prognosis".Clients seeking to avoid self-hosted infrastructureLaunched 4 Nov 2025Subscription / as-a-service
Testing solutions (HeartBeat, WebBeat, StressTest)Voice/web experience and load testing for contact centresContact-centre operatorsDivested to Voxology Dec 2024; IR retains resale rights; testing revenue of A$2.1m in FY26Service fees

IR Transact (payments observability)

OfferingDescriptionTarget customerLaunch / latestPricing model
Transact for Card PaymentsEnd-to-end monitoring of card-payment switching and authorisation flows; analyses transaction data to protect payment experienceCard issuers, acquirers, processors, top-tier banksLong-standing; v13.3 (2026)Term licence plus maintenance
High Value Payments (HVP)Real-time visibility and control of high-value payment flows (e.g., Fedwire, SWIFT, CHIPS); v13.3 adds ACI MTS TSI integrationGlobal systemically important banksFirst client deployed (top-10 bank), announced 24 Apr 2025; implementation completed FY26Term licence (details not disclosed)
Real-Time Payments monitoringObservability of instant-payment rails; Iris extension plannedBanks adopting real-time railsRoadmap (planned Iris extension)—
Iris for Card PaymentsNatural-language AI assistant purpose-built for card-payments observability; built-in IR correlation logic explains why an issue occurredPayments operations teamsBeta from May 2026 in Prognosis 13.3; free in beta (usage limits may apply)Utilisation-based intended; currently no charge in beta

IR Infrastructure (HPE NonStop)

OfferingDescriptionTarget customerLaunch / latestPricing model
Prognosis for HPE NonStopReal-time performance insight, pattern detection and proactive problem prevention for HPE NonStop environmentsBanks, exchanges, telcos and processors running NonStopIR's original franchise (since 1988); current v13.xTerm licence plus maintenance

AI and new-product portfolio (product-led growth)

OfferingDescriptionStatusRevenue model
Iris (platform AI interface)Conversational / natural-language AI interface integrated into Prognosis for deeper discovery; foundation for further AI offeringsLaunched 2 Dec 2025; first clients activated (FY26)Utilisation-based (SaaS)
Agentic SQA (IR Labs)IR's first stand-alone agentic AI product. It automates software quality assurance by turning static-analysis, fuzzer, sanitiser and CI signals into triaged, validated, developer-ready outputs. IR positions it as an evidence-first, reviewable system rather than a one-click autonomous fixer (per IR Labs job description).Beta and MVP released in FY26; first clients activatedUtilisation-based (SaaS)
AI-driven analyticsAI/ML analytics extracting additional value from data already collected by PrognosisIntroduced/expanded in FY26Bundled / utilisation

Professional services

Implementation, configuration and consulting services for licensed software. Revenue was A$3.3m in FY26, down 13% (FY26 Annual Financial Report).

Portfolio assessment

The portfolio is narrow and deep. Its moat lies in decades of domain-specific instrumentation (NonStop internals, payment-switch message flows, multi-vendor UC signalling) that general-purpose observability platforms do not replicate out of the box.

The weakness is that each legacy domain is either shrinking (on-premise UC) or mature (NonStop). The new AI products are, by management's own admission, at an early stage and not yet generating meaningful revenue (FY26 Directors' Report).

Financial Narrative

Basis: statutory A$ figures from the Annual Financial Reports and results releases for FY22–FY26, unless marked computed. IR does not report cost of sales or gross profit. Its expenses are presented by function (product & technology; sales, professional services & marketing; general & administration).

Income statement

Notes:

  • FY22 tax is computed as NPAT less PBT.

  • FY23 pro forma EBITDA is A$17.527m per the FY24 Annual Report reconciliation. The FY24 three-year index table shows A$17.575m, a minor discrepancy in the company's own documents.

  • FY22 statutory EBITDA, operating expense and D&A were not available in the reviewed FY22 extracts.

Margins and growth (computed)

Revenue CAGR (computed):

  • Statutory revenue FY2022–FY2026: about −2.2% a year (A$62.9m to A$57.6m).

  • Pro forma revenue FY2022–FY2026: about −4.7% a year (A$79.8m to A$65.8m).

  • Statutory revenue CAGR from the FY2020 peak (A$110.9m) to FY2026: about −10.3% a year.

Half-yearly progression: notes and sources

Source: H1 FY25 and H1 FY26 Interim Results. H2 figures are computed as full year less H1.

Balance sheet: notes and sources

Note: FY22 equity is the opening FY23 balance per the FY24 Annual Report statement of changes in equity. Goodwill and intangibles were fully written off in FY23. No R&D has been capitalised since FY24.

Cash flow: notes and sources

Note: FY22 net cash flow before financing activities (A$7.191m) is from the FY24 Remuneration Report index table. FY25 proceeds from the sale of the testing business were A$0.76m.

Ratios (computed unless noted)

Notes:

  • Net debt/EBITDA is not meaningful: IR has net cash in every year and negative EBITDA in FY26.

  • Invested capital = equity + lease liabilities − cash.

  • The cash conversion cycle approximates receivables days, because IR holds no inventory and has modest payables. It is structurally distorted by multi-year customer payment terms.

Commentary on trends, inflections and drivers

Revenue.

  • IR's statutory revenue has followed a renewal-cycle sawtooth around a declining trend: A$110.9m in FY20, A$78.5m in FY21, A$62.9m in FY22, A$69.8m in FY23, A$83.3m in FY24, A$68.3m in FY25 and A$57.6m in FY26.

  • The FY24 spike was a strong renewal year (large multi-year Infrastructure and Transact renewals plus the Fiserv deal), not structural growth. Pro forma revenue actually fell 1% that year.

  • The FY26 decline combined three things:

    • a soft renewals book (renewal TCV −21% to A$38.5m);

    • weaker second-half new business, with deferrals into FY27 amid protracted US procurement and compliance cycles;

    • shorter contract terms on new wins, attributed partly to client caution about AI-driven change (FY26 Directors' Report).

Profitability.

  • FY24 marked the cost-reset peak. Product and technology spend was cut 46% and headcount fell to 142, producing a 29.5% EBITDA margin.

  • FY25 kept costs down (expenses −5%) but revenue fell, and the effective tax rate normalised to 27.5% after R&D credits were used up.

  • FY26 swung to an EBITDA loss of A$2.1m from:

    • lower revenue;

    • a A$5.0m expected credit loss charge, of which A$3.8m related to a single client and was unrelated to software performance;

    • A$2.7m of FX losses;

    • a deliberate 29% increase in product and technology spend to A$17.4m (30% of revenue).

  • Excluding the credit loss, operating expenses were broadly flat at A$53.1m.

  • Positives: second-half EBITDA was positive (about A$1.0m, computed), and pro forma EBITDA remained positive at A$8.7m.

Balance sheet.

  • The balance sheet is very liquid: A$51.7m cash, no borrowings, current ratio 4.5x.

  • The largest asset is A$58.2m of trade receivables, reflecting extended payment terms granted on multi-year licence deals.

  • Receivables fell 21% in FY26 as collections exceeded new billings. This supported operating cash flow of A$12.6m despite near-zero profit.

  • The A$3.8m single-client provision shows that these long-dated receivables carry real credit risk.

Cash flow.

  • Cash generation has been consistent: A$13.0m (FY24), A$8.7m (FY25) and A$12.6m (FY26) of operating cash flow.

  • FY25 was depressed by A$4.4m of tax payments; FY26 benefited from a tax refund.

  • Interest income (A$3.6m in FY26) is now a meaningful earnings contributor.

  • The company has never bought back shares in the period reviewed.

Capital returns.

  • Dividends resumed in FY24 (2.0c) after a period of no dividends in FY22–FY23.

  • FY26 brought a 3.0c ordinary dividend plus a 2.0c special, about A$9.0m in total. That equals roughly 7.5x FY26 NPAT and about 73% of FY26 free cash flow, signalling the Board's view that cash exceeds investment needs.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Income Statement and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Revenue statutory (AUD Mn)

62.969.883.368.357.6

Revenue growth statutory (%)

-19.911.119.3-18.1-15.6

Pro forma revenue (AUD Mn)

79.875.674.874.365.8

Total contract value TCV (AUD Mn)

56.768.583.967.354.3

Total operating expenses incl impairment (AUD Mn)

—102.758.054.958.8

Impairment expense (AUD Mn)

—31.80.00.00.0

Other gains or losses (AUD Mn)

—1.4-0.92.1-1.6

Operating income EBIT before finance income (AUD Mn)

—-31.524.515.5-2.8

EBITDA statutory (AUD Mn)

—-19.724.615.9-2.1

EBITDA excluding impairment (AUD Mn)

—12.124.615.9-2.1

Pro forma EBITDA (AUD Mn)

24.517.516.721.58.7

Depreciation and amortisation (AUD Mn)

—11.80.10.40.7

Finance income (AUD Mn)

—2.22.23.03.6

Pre-tax income (AUD Mn)

-2.4-29.326.718.40.7

Income tax expense (benefit negative) (AUD Mn)

-4.0-0.1-0.45.1-0.5

Net income NPAT (AUD Mn)

1.5-29.227.113.41.2

NPAT excluding impairment (AUD Mn)

1.52.627.113.41.2

EPS basic (A cents)

0.90-16.9015.577.560.67

EPS diluted (A cents)

—-16.9015.187.430.67

Dividends declared per share total (A cents)

0.000.002.002.005.00

of which special dividend per share (A cents)

0.000.000.000.002.00

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

EBITDA margin statutory (%)

—-28.229.523.3-3.7

EBITDA margin excluding impairment (%)

—17.329.523.3-3.7

Operating EBIT margin (%)

—-45.129.422.7-4.9

Net margin (%)

2.4-41.932.619.62.1

Pro forma EBITDA margin on pro forma revenue (%)

30.723.122.328.913.2

Effective tax rate (%)

——-1.627.5-64.4

Income Statement

MetricH1FY2025H2FY2025H1FY2026H2FY2026

Revenue statutory (AUD Mn)

28.839.528.329.3

Pro forma revenue (AUD Mn)

36.637.734.431.4

EBITDA statutory (AUD Mn)

4.611.3-3.11.0

NPAT (AUD Mn)

4.68.8-1.52.7

Cash at period end (AUD Mn)

—40.643.651.7

Expense line (AUD Mn)

Expense line (AUD Mn)FY2023FY2024FY2025FY2026

Product and technology expense net (AUD Mn)

23.712.813.517.4

Sales professional services and marketing (AUD Mn)

40.938.734.130.8

General and administration (AUD Mn)

6.36.57.310.6

Expected credit loss expense within G and A (AUD Mn)

——0.15.0

Impairment (AUD Mn)

31.80.00.00.0

Total expenditure (AUD Mn)

102.758.054.958.8

Balance Sheet and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (AUD Mn)

—89.7114.2123.0119.4

Cash and equivalents (AUD Mn)

12.318.631.940.651.7

Borrowings short term (AUD Mn)

0.00.00.00.00.0

Borrowings long term (AUD Mn)

0.00.00.00.00.0

Lease liabilities current (AUD Mn)

—1.61.30.70.5

Lease liabilities non-current (AUD Mn)

—1.50.41.11.0

Net debt (negative = net cash, excl leases) (AUD Mn)

-12.3-18.6-31.9-40.6-51.7

Total equity (AUD Mn)

87.159.988.4100.698.0

Goodwill and intangibles (AUD Mn)

—0.00.00.00.0

Trade receivables current (AUD Mn)

—40.941.640.835.9

Trade receivables non-current (AUD Mn)

—22.531.933.022.3

Deferred revenue (AUD Mn)

—14.113.911.510.6

Current assets (AUD Mn)

—63.177.984.991.1

Current liabilities (AUD Mn)

—27.224.920.820.1

Working capital (AUD Mn)

—35.853.064.071.1

Net tangible assets per share (A cents)

———56.7354.28

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Cash receipts from customers (AUD Mn)

—76.372.466.764.7

Operating cash flow (AUD Mn)

—13.813.08.712.6

Income taxes paid (refunded negative) (AUD Mn)

—1.71.04.4-0.1

Capex property plant and equipment (AUD Mn)

—0.30.00.50.3

Capitalised development (AUD Mn)

—7.50.00.00.0

Free cash flow OCF less capex and capitalised dev (AUD Mn)

—6.013.08.212.4

Lease principal payments (AUD Mn)

—1.61.61.40.7

Interest received (AUD Mn)

—2.22.32.93.6

Dividends paid (AUD Mn)

0.00.00.03.53.5

Share buybacks (AUD Mn)

0.00.00.00.00.0

Net cash flow before financing (AUD Mn)

7.27.215.312.816.0

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025FY2026

ROE company reported (%)

2-4037141

ROA on average total assets (%)

——26.611.31.0

ROIC NOPAT at 30pct notional tax on end capital (%)

—-49.729.417.5-4.1

Current ratio (x)

—2.323.134.074.54

Debt to equity borrowings only (x)

0.000.000.000.000.00

Lease-adjusted debt to equity (x)

—0.050.020.020.02

EBITDA to interest paid (x)

——256157-22

Asset turnover (x)

——0.820.580.48

Receivables days total receivables over revenue (days)

—332322394369

Cash conversion OCF over EBITDA (%)

—1145355—

Revenue by Region

Region (local currency)FY2023FY2024FY2025FY2026

Americas revenue (USD Mn)

28.139.130.928.1

Asia Pacific revenue (AUD Mn)

17.215.815.511.0

Europe revenue (GBP Mn)

5.84.12.42.7

Region growth (%)

Region growth (%)FY2024FY2025FY2026

Americas growth in US$ (%)

39-21-9

Asia Pacific growth in A$ (%)

-8-2-29

Europe growth in GBP (%)

-28-4313

Revenue by Region (FY2025–FY2026)

Region (AUD Mn)FY2025FY2026

Americas revenue (AUD Mn)

48.141.3

Asia Pacific revenue (AUD Mn)

15.511.0

Europe revenue (AUD Mn)

4.75.3

Geographic Revenue

TerritoryFY2026 pro forma (AUD Mn)Change vs FY2025

Americas

45.0−13%

APAC

13.8−7%

Europe

7.0−11%

Share Price and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Closing share price at 30 June (AUD)

0.420.390.930.420.27

Annual share price change (%)

—-7.1138.5-54.8-35.7

Period (to 30 Jun 2026 unless noted)

Price return

Basis

———

1 year

−35.7%

A$0.42 to A$0.27

———

3 years

−30.8%

A$0.39 to A$0.27

———

4 years

−35.7%

A$0.42 to A$0.27

———

5 years

—

FY21 closing price not confirmed in reviewed sources; the stock traded as high as about A$2.13 within FY21

———

Latest verified price

A$0.295 (21 Aug 2026)

InvestSMART

———

52-week range (as of Mar 2026)

A$0.27 – A$0.51

Market data (Halo)

———

Valuation Multiples

MultipleIR valueComment

Market capitalisation

About A$53.3m

Cum-dividend

Enterprise value (market cap − cash + leases)

About A$3.1m

About A$12.1m after the A$9.0m October 2026 dividend outflow, holding price constant

P/E (FY26 basic EPS 0.67c)

About 44x

Depressed earnings

P/E (FY25 basic EPS 7.56c)

About 3.9x

—

EV/Pro forma EBITDA (A$8.7m)

About 0.4x

Pre-dividend EV

EV/Sales (FY26 statutory)

About 0.05x

About 0.2x post-dividend

P/B (book A$98.0m)

About 0.54x

Book is almost entirely cash and receivables

Dividend yield (5.0c incl special)

About 16.9%

10.2% on the 3.0c ordinary dividend alone

Per-Share Data and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Ordinary dividend declared per share (A cents)

0.00.02.02.03.0

Special dividend declared per share (A cents)

0.00.00.00.02.0

Franking (%)

——100100100

Dividends paid in cash during year (AUD Mn)

0.00.00.03.53.5

Analyst Conclusions

Management guidance

No quantitative FY27 guidance has been issued: - Qualitative guidance (FY26 Results, 27 Aug 2026):

  • continued investment in new products, with PLG weighing on profit over the short to medium term;

  • the FY27 renewals book is weighted to the second half;

  • focus on commercialising new products, minimising churn, and growing new-client, expansion and SaaS revenue.

Capital allocation: 30–35% of available capital to innovation; 20–35% flexibility reserves (including M&A); 30–35% contingency; dividends of at least 25% of free cash flow.

Consensus growth expectations

Not publicly verifiable. Coverage is limited and historic consensus (FNArena) appears stale.

Bull case

  1. The balance sheet caps downside. Net cash of about A$43m after the Oct 2026 dividend is close to the market capitalisation. Investors are paying little for a business that still generated A$12.6m of operating cash flow and A$8.7m of pro forma EBITDA in a trough year.

  2. Payments is a real growth vector. Transact grew statutory revenue 18% in FY26. HVP is live at a top-10 bank with other global banks engaged. Iris for Card Payments brings AI into a domain where IR monitors more than 80 billion transactions a year. Each additional tier-one HVP client would be material relative to A$10.9m of annual new-business TCV.

  3. A second-half-weighted FY27 renewal book plus new AI products could produce a statutory rebound similar to FY24, when revenue rose 19% and NPAT reached A$27.1m. The cost base is controlled (expenses ex-credit losses broadly flat at A$53.1m), giving high operating leverage to renewal timing.

Bear case

  1. The core is in structural decline. Pro forma revenue has fallen from A$79.8m (FY22) to A$65.8m (FY26), and the decline accelerated to −12% in FY26. Collaborate NRR is stuck at 83%, and down-sell has now spread to Transact and Infrastructure.

  2. New products may not scale. Subscription revenue fell 54% in FY26. New-client TCV hit only 29% of target. A 30%-of-revenue R&D budget is minuscule against AI-heavy platforms (Datadog's R&D is 45% of a US$3.4bn base). IR may be outspent in exactly the AI features it is betting on.

  3. Earnings quality and credit risk. About 67% of revenue is upfront licence recognition with multi-year payment terms. That leaves A$58.2m of receivables (about 369 days of revenue), and FY26 already produced a A$3.8m single-client loss. Further provisions, or slower collections as contract terms shorten, would erode the cash story that underpins the valuation.

Key catalysts and monitorables (next 12 months)

ItemExpected timingWhat to watch
FY26 Annual Report (top-20 holders)About 16 Oct 2026Identity of the Jul 2026 substantial holder change; founder stake
2026 AGMAbout Nov 2026 (date not confirmed)Remuneration vote; any FY27 commentary; Board renewal (Hitz and Brayan's terms were due by the 2026 AGM per the FY24 report)
H1 FY27 trading updateAbout Nov–Dec 2026 (based on prior pattern)New-business TCV vs FY26; AI product utilisation metrics
H1 FY27 resultsAbout Feb 2027Subscription/SaaS revenue trajectory; credit-loss recoveries
HVP second clientAny timeConversion of engaged global banks
Iris general availability and monetisationFY27Move from free beta to paid utilisation; HVP/real-time payments extensions (Prognosis 13.4)
Agentic SQA commercial launchFY27Paying customers; pricing
M&A from flexibility reserveOpportunisticDeal size and fit versus the "right-sized, synergistic" criterion
H2 FY27 renewalsJan–Jun 2027Size and term of renewal cohort; down-sell
Mandatory climate reporting preparationFY27Disclosure readiness for FY28

Concluding analyst verdict

Integrated Research is a classic "cash shell with a declining annuity and an option attached."

The annuity is a 38-year-old observability franchise with genuine domain depth in NonStop, payments and multi-vendor UC. It still converts revenue into cash reliably: A$12.6m of operating cash flow in FY26 despite an EBITDA loss. It carries no debt and has no goodwill to impair. That annuity is shrinking, though, and the decline is no longer confined to Collaborate. In FY26 pro forma revenue fell 12%, renewal TCV fell 21%, new-business TCV fell 21%, and management reports down-sell across Transact and Infrastructure in the Americas.

The option is the PLG and AI portfolio: Iris, Iris for Card Payments, HVP, Prognosis Elevate and IR Labs' Agentic SQA. The direction is strategically sensible. IR's trusted, deep-in-the-stack data access in regulated institutions is a credible foundation for domain-specific AI assistants. Execution evidence, however, is thin. Products are in beta or at first-client stage, subscription revenue halved, and the executive scorecard shows new-client TCV at 29% of target.

The market is pricing the company at roughly net cash: enterprise value of about A$3–12m depending on dividend timing, and about 0.5x book. That valuation implicitly assumes the operating business is worth close to nothing, which looks too punitive while it still produces A$8–13m of annual operating cash flow. Yet value realisation depends on one of three things:

  • stabilising pro forma revenue;

  • demonstrable AI monetisation;

  • capital returns or a control transaction, in which the founder's 28.9% stake is pivotal.

Verdict: a deep-value, high-uncertainty special situation rather than a growth investment. Downside is cushioned by cash and the dividend policy. Upside requires visible evidence in H1 FY27 that new-business TCV and utilisation revenue are inflecting. The most important near-term data points are the H1 FY27 trading update, any second HVP win, and the conversion of Iris from free beta to paid usage. Without those, the likeliest path is continued managed decline funded by, and gradually consuming, the cash pile.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenurePrior rolesEducation

Ian Lowe

CEO (from 1 Oct 2024) and Managing Director (Board from Oct 2024)

About 2 years

CEO, Wealth99; CEO, EP&T Global; CEO and Executive Director, Adslot (ASX); about 25 years of technology leadership in big-data software for media, finance and sustainability

—

Christian Shaw

Chief Financial Officer (joined Jan 2024; CFO from 1 Mar 2024); also responsible for People & Culture and Legal

About 2.5 years

CFO roles at AJG Australia, Multicom Resources, Unith Limited, Moko Social Media, iCash Payment Systems

B.Bus (UTS); CPA

Leanne Ralph

Company Secretary (Nov 2024)

About 2 years

Founder, Boardworx Australia; outsourced company secretary to Appen, ImpediMed, SenSen Networks and others; NED of Dicker Data (ASX)

B.Bus (UTS); FGIA; GAICD

“—” = not publicly disclosed.

Board of Directors

DirectorRoleAppointedIndependenceCommitteesBackground

Peter Lloyd (MAICD)

Chair

Director Jul 2010; Chair Mar 2021

Independent NED (tenure over 16 years)

Board Chair; member of ARC, PRNC, TIC

45+ years in computing; 35 years in payments solutions for banks; proprietor of The Grayrock Group; NED of Taggle Pty Ltd

Ian Lowe

CEO and MD

Oct 2024

Executive

—

As above

Michael Hitz (BE Hons)

NED

Oct 2023

Independent

Chair, Technology & Innovation Committee; member, ARC

Former Partner and MD, Boston Consulting Group (TMT); investor with a pan-Asian fund; Director, Institute for Economics and Peace

Mark Brayan (BSurv Hons, MBA AGSM)

NED

Nov 2023

Independent

Chair, People, Remuneration & Nomination Committee; member, TIC

Former CEO/MD of Appen (ASX), Soprano Design, MineSite Technologies and of IR itself; Chair of SenSen Networks (ASX) and Shorthand

Kate Greenhill (BEc, FCA, GAICD)

NED

Apr 2024

Independent

Chair, Audit & Risk Committee; member, PRNC

Former PwC Partner (Australia and UK); Director of Total Risk Management and Intersect Australia; ex-Director of Australian Ethical Investment

Directors' Remuneration

PersonSalary/feesSTI/bonusSuperannuationLong service leaveShare-based (LTI)Total

Ian Lowe (CEO & MD)

535,600105,00030,0008,92673,632753,158

Christian Shaw (CFO)

387,00085,00030,0006,44949,539557,988

Peter Lloyd (Chair)

165,536—19,864——185,400

Mark Brayan

91,964—11,036——103,000

Kate Greenhill

91,964—11,036——103,000

Michael Hitz

91,964—11,036——103,000

Board & Management Changes

DateChangeContext

Sep 2023 – Mar 2024

Brackin, Myers, Scott and Aston retire; Hitz, Brayan and Greenhill appointed

Board renewal during the turnaround

Feb–Mar 2024

Interim CFO Matthew Walton departs; Christian Shaw becomes CFO

Finance leadership change

16–17 Jul 2024

John Ruthven steps down as MD; CEO transition announced

The Board sought a leader from outside IR's product areas to find new revenue sources

1 Oct 2024

Ian Lowe starts as CEO (later appointed MD)

Product-led growth mandate

Oct–Nov 2024

Will Witherow replaced as Company Secretary by Leanne Ralph

Outsourced company-secretarial model

16 Jan 2025

Ruthven's employment ends (after gardening leave)

Termination benefit of A$176,061 recognised in FY25

Major Shareholders

HolderShares% of issued capitalDate / source

Stephen John Killelea (founder; holdings via associated entities)

52,218,23128.92%

Sep 2025 register data (MarketScreener); 29.71% (51.88m shares) per the 20 Sep 2023 substantial holder notice

Unidentified holder

——

Form 604 change in substantial holding lodged 14 Jul 2026; holder identity not captured in reviewed sources

Other top-10 holders

Not publicly disclosed in reviewed sources

—

Top-20 holder list expected in the FY26 Annual Report (scheduled about 16 Oct 2026)

Institutional ownership (SEC 13F-type filers)

about 54,754 shares

about 0.03%

Fintel, Sep 2025 (Dimensional, Old Westbury); immaterial

Directors' Shareholdings

DirectorSharesOther interests

Peter Lloyd

51,263—

Mark Brayan

260,000—

Michael Hitz

300,000

Bought on market in Dec 2025 at about A$0.31–0.35

Kate Greenhill

90,000

Bought Nov 2025 at about A$0.31

Ian Lowe

0

984,621 performance rights

Christian Shaw

0

847,182 performance rights

Competitive Landscape

Competitors by Segment

SegmentCompetitorTypeRevenue (latest public)Positioning vs IR

Collaborate (UC&CX observability)

Nectar Services Corp.

Private specialist

—

Direct multi-vendor UC monitoring rival; strong in contact-centre and Teams/Zoom/Webex observability

Collaborate

Vyopta

Private specialist

—

UC&C analytics and monitoring; competes for enterprise UC estates

Collaborate

Martello Technologies (TSXV: MTLO)

Listed specialist

—

Microsoft 365/Teams digital-experience monitoring (Vantage DX)

Collaborate

Unify Square (PowerSuite)

Private specialist

—

Teams/Zoom management and monitoring

Collaborate

Microsoft (native Teams Call Quality Dashboard / admin tooling)

Platform vendor

n/a (segment not separable)

Native tooling narrows third-party value; this is IR's key structural threat in UC

Collaborate

Cisco (ThousandEyes, Webex Control Hub)

Platform vendor

—

Native and network-path observability for Cisco estates

Collaborate (testing, adjacent)

Cyara (incl. Spearline)

Private CX assurance

—

CX testing leader; competes with the divested testing products

Transact (payments observability)

INETCO Systems

Private specialist

—

Closest direct payments-transaction monitoring rival

Transact / cross-domain

Splunk (Cisco, acquired 2024)

Platform

n/a (inside Cisco)

General log analytics used for payments monitoring

Cross-domain observability

Dynatrace (NYSE: DT)

Listed platform

US$2,018m, FY ended Mar 2026 (+19%)

AI-powered full-stack observability; a Gartner MQ Leader (2025)

Cross-domain observability

Datadog (NASDAQ: DDOG)

Listed platform

About US$3.43bn, CY2025 (about +28%)

Cloud-native observability; rapid AI feature cadence

Infrastructure (HPE NonStop)

HPE native NonStop performance tooling

Platform vendor

—

Built-in alternative; IR is the established third-party specialist

“—” = not publicly disclosed.

Peer Comparison FY2025

MetricIntegrated Research (FY ended Jun 2026)Dynatrace (FY ended Mar 2026)Datadog (CY2025)

Revenue

A$57.6m (about US$37m)

US$2,018m

About US$3,430m

Revenue growth

−16% statutory; −12% pro forma

+19% (+17% cc)

About +28%

GAAP operating margin

−4.9% (EBIT before finance income)

About 12% (GAAP operating income US$245m; computed)

—

Non-GAAP / adjusted margin

Pro forma EBITDA margin 13.2%

Non-GAAP operating margin about 29% (US$592m; computed)

Non-GAAP operating margin about 22% (FY25 guidance basis)

R&D intensity

30% of revenue

About 24% (computed from a US$89.7m, 23% increase)

45% (FY2025 10-K)

Balance sheet

Net cash A$51.7m; no debt

Net cash (buybacks of US$479m in FY26)

Net cash

Recent Developments

FY26 headcount rose by 7 to 138.

Company Snapshot

138

Employees

1988

Founded

Sydney, Australia

Headquarters

SWOT Analysis

Strengths

  • Fortress balance sheet. A$51.7m cash and no borrowings at 30 Jun 2026, about equal to market capitalisation of about A$53m (FY26 Annual Financial Report; computed).
  • Consistent cash generation through the cycle. Operating cash flow was A$13.0m, A$8.7m and A$12.6m in FY24–FY26, even when FY26 NPAT was only A$1.2m.
  • Highly recurring underlying revenue. 92% of FY26 pro forma revenue is from term-based contracts (FY26 Investor Presentation).
  • Blue-chip, long-tenured clients. JPMorgan Chase has been a client for about 30 years and renewed for five years in Mar 2025 (US$6.23m). A top-10 bank adopted HVP.
  • Transact resilience. Statutory revenue +18% in FY26, and TCV for Transact and Infrastructure reached 128% of target (FY26 Remuneration Report).
  • Conservative accounting. No capitalised R&D since FY24 and nil goodwill/intangibles, so the balance sheet is almost entirely cash and receivables (NTA 54.3c per share).

Weaknesses

  • Persistent revenue decline. Statutory revenue has fallen from A$110.9m (FY20) to A$57.6m (FY26), a CAGR of about −10%. Pro forma revenue fell 12% in FY26.
  • Collaborate erosion. FY26 revenue −27%, net revenue retention 83%, and Collaborate is still the largest product line (FY26 Directors' Report).
  • Revenue-recognition volatility. About 67% of statutory revenue is upfront licence fees, so results depend heavily on the renewal calendar. Renewal TCV fell 21% in FY26.
  • Credit-risk concentration. FY26 expected credit loss of A$5.0m, of which A$3.8m related to one client. Receivables are A$58.2m, or about 369 days of revenue.
  • Sub-scale R&D. Product and technology spend of A$17.4m is tiny relative to global observability platforms (Datadog R&D about US$1.55bn in 2025).
  • Missed growth KPIs. New-client TCV reached only 29% of the A$24.5m FY26 target and total TCV 74% of target (FY26 Remuneration Report). New-business TCV fell 21% to A$10.9m.

Opportunities

  • High Value Payments expansion. Implementation completed with a top-10 US bank, and engagement with other major global banks is progressing (FY26 Investor Presentation).
  • AI monetisation. Iris (Dec 2025), Iris for Card Payments (beta May 2026) and Agentic SQA are moving to usage-based revenue.
  • Real-time payments. Planned Iris extension to real-time payments (Jun 2026 PR) as instant payment rails proliferate.
  • Observability-as-a-service. Prognosis Elevate (Nov 2025) offers a path to recapture clients migrating away from self-hosted tools.
  • Capital redeployment. 20–35% of available capital is reserved for synergistic M&A (FY27 framework); with net cash of about A$43m after the Oct 2026 dividend, bolt-ons are fundable.
  • US public sector and health. New-client wins in FY26 included large US Government agencies, health and defence (H1 FY26 and FY26 results).

Threats

  • Native tooling from platform vendors (Microsoft, Cisco, HPE), flagged by IR as a material risk (FY24 Annual Report).
  • AI-native competitors. Large observability platforms (Dynatrace, Datadog, Splunk/Cisco) are adding AI assistants with far greater resources. IR's FY26 risk section names AI-driven competitive disruption explicitly.
  • Shorter contract terms and slower procurement, which compress upfront licence revenue (FY26 Directors' Report).
  • FX volatility. A$2.7m of FX losses in FY26, with about 72% of revenue earned in US$.
  • Talent scarcity. Highly technical skills are needed in product and sales, a recurring risk in FY24–FY26 reports.
  • Founder-holder overhang. Killelea's 28.9% stake gives one holder decisive influence over any control transaction; past sell-downs (6.64m shares in about 2017) depressed the share price.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
20 Mar 2025 (context)JPMorgan Chase 5-year renewal, US$6.23mAnchor-client retention; Transact/Infrastructure stickiness
24 Apr 2025First HVP deployment at a top-10 bank (Fedwire/SWIFT/CHIPS)First new payments product beyond cards
27–30 Apr 2025IR exhibits HVP at the Nacha Smarter Faster Payments conferenceGo-to-market push into US payments
17 Jul 2025FY25 trading update; some expected opportunities slip into FY26Early signal of procurement delays; shares −17%
26 Aug 2025FY25 results: revenue −18% to A$68.3m; NPAT A$13.4m (−51%); cash A$40.6m; 2.0c dividendPro forma revenue steady; PLG pivot formalised
31 Aug 2025FY24 LTI tranche 2 fails its A$1.20 hurdle; FY23 LTI final testExecutive equity incentives out of the money
Sep 2025Register data show Killelea at 52.2m shares (28.9%)Founder control steady
21 Oct 2025FY25 final dividend paid (A$3.547m)Second consecutive annual dividend
4 Nov 2025Prognosis Elevate (observability-as-a-service) launchedFirst as-a-service UC&C offering
14 Nov 2025H1 FY26 trading update: EBITDA loss of A$3–8m expected, TCV and revenue down about 4%, large credit-loss provisionGuidance shock; shares fell about 15–18%
24 Nov 20252025 AGM; CEO presentation on PLGBoard re-endorses strategy
27 Nov 2025Director Kate Greenhill buys 90,000 shares (about A$0.31)Insider buying
1 Dec and 5 Dec 2025Director Michael Hitz buys 150,500 and 149,500 shares (about A$0.31–0.35)Insider buying
2 Dec 2025Iris (conversational AI intelligence layer) launchedFirst AI-powered product
14–15 Jan 2026FY26 LTI performance rights issued (Lowe 581,395; Shaw 348,837); cessation of lapsed securitiesIncentive refresh at A$0.43 VWAP basis
26 Feb 2026H1 FY26 results: revenue A$28.3m (−2%), EBITDA −A$3.1m, NPAT −A$1.5m, cash A$43.6m (+8%); new-business TCV +10% to A$8.3m; new clients in government, health and defenceCredit loss and investment weigh; new business improving
16–23 Mar 2026Notice of investor eventInvestor engagement
24 Mar 2026Investor session on PLG and AIManagement flags near-term profit decline
14 Apr 2026Cessation of securities (lapsed rights)Housekeeping
May 2026Prognosis 13.3 released; Iris for Card Payments beta; HVP–ACI MTS TSI integrationProduct cadence
22–23 Jun 2026Iris for Card Payments announced via PR NewswireAI extended into the payments franchise
24 Jun 2026Cessation of securitiesHousekeeping
30 Jun 2026FY26 year-end; share price closes at A$0.27Down from A$0.42 a year earlier
14 Jul 2026Form 604 change in substantial holding (holder not identified in reviewed sources); cessation of securitiesRegister movement to monitor
24 Jul 2026FY26 trading update: revenue A$56–58m, pro forma A$64–66m, EBITDA −A$2–4m, cash A$51.7mPre-announcement; shares about −3%
17 Aug 2026FY26 results date and webinar noticeHousekeeping
27 Aug 2026FY26 results: revenue A$57.6m (−16%), EBITDA −A$2.1m, NPAT A$1.2m (−91%); dividend 3.0c plus 2.0c special; capital allocation frameworkCash returned while PLG continues
31 Aug 2026FY24 LTI tranche 3 test (A$1.60 hurdle); FY22 executive options (A$1.98 strike) expireExpected lapse; reduces dilution overhang
3 Sep 2026Record date for the 5.0c fully franked dividends (about A$9.0m)—
15 Oct 2026 (upcoming)Dividend payment dateCash falls by about A$9.0m
About 16 Oct 2026 (expected)FY26 Annual Report (full report with top-20 holders)Will update ownership data

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Income Statement: Revenue & Gross Profit: Revenue statutory fell from AUD 62.9 Mn in FY2022 to AUD 57.6 Mn in FY2026.
Integrated Research Limited — Income Statement: Revenue & Gross Profit
Series (AUD Mn)FY2022FY2023FY2024FY2025FY2026
Revenue statutory62.969.883.368.357.6
Pro forma revenue79.875.674.874.365.8

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.